TrialKit - 2026 Pricing, Features, Reviews & Alternatives

TrialKit, developed by Crucial Data Solutions, is a unified eClinical platform for sponsors, CROs, research sites, and research institutions seeking greater control over clinical study design, execution, and analysis. By bringing clinical data collection, study management, and AI-powered intelligence into one environment, TrialKit helps teams manage complex research workflows while maintaining flexibility as study requirements evolve.

Unified Clinical Research Technology

TrialKit provides a comprehensive suite of eClinical capabilities, including electronic data capture (EDC), ePRO/eCOA, eSource, eConsent, randomization and trial supply management (RTSM), medical coding, adjudication, medical imaging (PACS), eTMF, and virtual visits. These tools support traditional, hybrid, and decentralized research while reducing reliance on separate systems for clinical data and study operations.

The platform's unified architecture supports consistent data management across applications, with open REST APIs enabling integration with external systems, laboratory data sources, and third-party applications.

AI-Powered Study Development and Intelligence With Floyd

Floyd, TrialKit's AI model, works directly within the platform to support activities across the clinical study lifecycle. Purpose-built for TrialKit, Floyd understands its underlying data model, APIs, study architecture, and configuration, allowing it to assist with study development, validation, simulation, and analysis.

Starting with protocol requirements, Floyd can help generate configured study components, including eCRFs, visit schedules, edit checks, calculations, and workflows. Research teams can then review, refine, and validate these configurations within TrialKit, retaining control over study design and changes as requirements evolve.

Floyd also supports study simulation and validation using synthetic participants and datasets, allowing teams to test configurations and evaluate potential issues before enrollment begins. During study execution, teams can use Floyd to query clinical data, investigate trends, and evaluate study performance. These capabilities support informed decision-making while keeping scientific, clinical, and regulatory oversight with the research team.

Flexible Data Collection and Study Oversight

TrialKit is accessible through web and native applications for iOS, Android, and macOS, giving authorized users flexible access to study data and workflows. Mobile capabilities support site-based and remote data collection, including bring-your-own-device (BYOD) options for participant-reported outcomes.

Configurable workflows, reusable study components, and granular role-based permissions allow teams to adapt studies without extensive programming. Audit trails, access controls, and data validation features support traceability, data integrity, and the requirements of regulated clinical research.

Predictable Pricing and Long-Term Flexibility

TrialKit's Platform License Agreement (PLA) provides predictable monthly platform pricing without incremental change-order fees for routine study modifications. Combined with AI-assisted study building, reusable configurations, and self-service management capabilities, this approach gives organizations flexibility to adapt studies while managing technology costs.

From emerging biotech companies to CROs managing multi-study portfolios, TrialKit brings together clinical research applications, flexible study management, and Floyd's AI capabilities to support study execution and oversight within a unified environment.